Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toe digital block anesthesia latency with bupivacaine or lidocaine, with or without epinephrine
ACTRN12616001610426Phase 4Completed
- Sponsor
- University of Seville
- Start
- Feb 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine, lidocaine and epinephrine in ingrown nail (4 arms), sponsored by University of Seville. Primary endpoints: Toe pain response to pinprick test and Latency time of anesthesia. Started Feb 2016; status: completed.
02
Drugs
bupivacainelidocaineepinephrine
03
Conditions
ingrown nail
Beyond the preview
Go deeper on ACTRN12616001610426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001610426.